- Home
- BDTX vs PTMN Comparison
BDTX vs PTMN Comparison
Compare BDTX & PTMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDTX
- PTMN
- Stock Information
- Founded
- BDTX 2014
- PTMN 2006
- Country
- BDTX United States
- PTMN United States
- Employees
- BDTX N/A
- PTMN N/A
- Industry
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- PTMN Finance: Consumer Services
- Sector
- BDTX Health Care
- PTMN Finance
- Exchange
- BDTX Nasdaq
- PTMN Nasdaq
- Market Cap
- BDTX 181.4M
- PTMN 165.9M
- IPO Year
- BDTX 2020
- PTMN N/A
- Fundamental
- Price
- BDTX $2.93
- PTMN $12.48
- Analyst Decision
- BDTX Strong Buy
- PTMN Hold
- Analyst Count
- BDTX 6
- PTMN 1
- Target Price
- BDTX $14.83
- PTMN $14.00
- AVG Volume (30 Days)
- BDTX 969.2K
- PTMN 39.6K
- Earning Date
- BDTX 08-05-2025
- PTMN 08-07-2025
- Dividend Yield
- BDTX N/A
- PTMN 15.63%
- EPS Growth
- BDTX N/A
- PTMN N/A
- EPS
- BDTX 0.09
- PTMN N/A
- Revenue
- BDTX $70,000,000.00
- PTMN $58,024,000.00
- Revenue This Year
- BDTX N/A
- PTMN N/A
- Revenue Next Year
- BDTX N/A
- PTMN $12.17
- P/E Ratio
- BDTX $33.20
- PTMN N/A
- Revenue Growth
- BDTX N/A
- PTMN N/A
- 52 Week Low
- BDTX $1.20
- PTMN $11.48
- 52 Week High
- BDTX $6.75
- PTMN $19.95
- Technical
- Relative Strength Index (RSI)
- BDTX 56.77
- PTMN 48.65
- Support Level
- BDTX $3.02
- PTMN $12.45
- Resistance Level
- BDTX $3.28
- PTMN $12.73
- Average True Range (ATR)
- BDTX 0.19
- PTMN 0.22
- MACD
- BDTX -0.01
- PTMN -0.04
- Stochastic Oscillator
- BDTX 53.33
- PTMN 6.12
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
About PTMN Portman Ridge Finance Corporation
Portman Ridge Finance Corp Inc is a non-diversified closed-end investment company. The company originates, structures, and invests in secured term loans, bonds or notes, and mezzanine debt in privately-held middle market companies but may also invest in other investments such as loans to publicly traded companies, high-yield bonds, and distressed debt securities. The company's investment objective in the Debt securities portfolio is to generate current income and, to a lesser extent, capital appreciation from the investments in senior secured term loans, mezzanine debt, and selected equity investments in privately-held middle market companies.